A detailed history of Readystate Asset Management LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Readystate Asset Management LP holds 869,915 shares of EXAS stock, worth $58.3 Million. This represents 2.03% of its overall portfolio holdings.

Number of Shares
869,915
Previous 900,231 3.37%
Holding current value
$58.3 Million
Previous $47.8 Billion 0.51%
% of portfolio
2.03%
Previous 1.46%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

SELL
$40.91 - $56.0 $1.24 Million - $1.7 Million
-30,316 Reduced 3.37%
869,915 $47.6 Billion
Q2 2025

Aug 07, 2025

BUY
$40.31 - $58.08 $36 Million - $51.9 Million
893,827 Added 13957.32%
900,231 $47.8 Billion
Q1 2025

May 06, 2025

BUY
$43.04 - $58.51 $275,628 - $374,698
6,404 New
6,404 $277 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Readystate Asset Management LP Portfolio

Follow Readystate Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Readystate Asset Management LP with notifications on news.